ASX:AGN Argenica Therapeutics (AGN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Argenica Therapeutics Stock (ASX:AGN) 30 days 90 days 365 days Advanced Chart Get Argenica Therapeutics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$104.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewArgenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.Read More… Receive AGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AGN Stock News HeadlinesArgenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial ProgressMay 23 at 5:29 AM | msn.comASX Penny Stock Highlights For May 2025May 6, 2025 | uk.finance.yahoo.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.May 25, 2025 | Porter & Company (Ad)Argenica Therapeutics Reports Reduced Losses Amid Increased R&D CostsFebruary 11, 2025 | tipranks.comArgenica Therapeutics Ltd Ordinary Shares AGNJanuary 10, 2024 | morningstar.comHere's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn SituationJanuary 9, 2024 | finance.yahoo.comArgenica Therapeutics Limited (AGN.AX)January 5, 2024 | finance.yahoo.comArgenica Therapeutics Insider Ups Holding During YearJanuary 5, 2024 | finance.yahoo.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryInsurance Current SymbolASX:AGN CIKN/A Webargenica.com.au Phone61 8 9329 3396FaxN/AEmployees22,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,480,000.00 Net Margins-238.05% Pretax MarginN/A Return on Equity-60.20% Return on Assets-27.35% Debt Debt-to-Equity RatioN/A Current Ratio6.75 Quick Ratio12.21 Sales & Book Value Annual Sales$2.60 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.13 per share Price / BookN/AMiscellaneous Outstanding Shares128,090,000Free FloatN/AMarket Cap$104.40 million OptionableNot Optionable Beta0.79 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (ASX:AGN) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argenica Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argenica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.